Suchergebnisse - "heart muscle ischemia"

  1. 1
  2. 2

    Quelle: ESC Heart Fail
    ESC Heart Failure
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    ESC Heart Failure, Vol 10, Iss 1, Pp 568-577 (2023)

    Dateibeschreibung: application/pdf

  3. 3

    Weitere Verfasser: Fuat Polat Eser Durmaz Kıvanç Yalın et al.

    Quelle: Kardiologiia. 62:56-65

  4. 4
  5. 5
  6. 6
  7. 7

    Quelle: LANCET
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    instname
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    Lancet, Vol. 395, no.10225, p. 698-708 (2020)
    Bone and Joint Institute

    Schlagwörter: Postoperative Complications/epidemiology, Male, Internationality, Femoral Neck Fractures/epidemiology, Arthroplasty, Replacement, Hip, Comorbidity, R Medicine (General), nursing homes, Time-to-Treatment/statistics & numerical data, Fracture Fixation, Internal, 0302 clinical medicine, Activities of Daily Living, Medicine and Health Sciences, Fracture Fixation, Internal/methods, Sepsis/epidemiology, Cardiovascular Diseases/mortality, Aged, 80 and over, Residence Characteristics/statistics & numerical data, accelerated surgery, adult, aged, Article, bleeding, cerebrovascular accident, controlled study, female, hazard ratio, heart infarction, hip fracture, hip hemiarthroplasty, hip surgery, human, major clinical study, male, middle aged, mortality, multicenter study, open reduction (procedure), osteosynthesis, outcome assessment, pneumonia, priority journal, randomized controlled trial, risk reduction, sepsis, total hip replacement, venous thromboembolism, cardiovascular disease, clinical trial, comorbidity, comparative study, daily life activity, delirium, dementia, demography, diabetes mellitus, early intervention, femoral neck fracture, heart muscle ischemia, hemiarthroplasty, hip replacement, international cooperation, nursing home, open fracture reduction, postoperative complication, postoperative hemorrhage, procedures, proportional hazards model, time to treatment, treatment outcome, very elderly, Infections/epidemiology, Middle Aged, 3. Good health, Treatment Outcome, Cardiovascular Diseases, RC Internal medicine, Diabetes Mellitus/epidemiology, Female, Hip Fractures/epidemiology, Infections, Early Medical Intervention/methods, 03 medical and health sciences, Arthroplasty, Replacement, Hip/methods, Early Medical Intervention, Diabetes Mellitus, Humans, Mortality, Myocardial Ischemia/epidemiology, Proportional Hazards Models, Aged, Postoperative Hemorrhage/epidemiology, Hip Fractures, Hemiarthroplasty/methods, Dementia/epidemiology, Delirium, Delirium/epidemiology, Femoral Neck Fractures, Open Fracture Reduction/methods, Dementia, Hemiarthroplasty, aged, 80 and over

    Dateibeschreibung: application/pdf

  8. 8

    Quelle: BMC Cardiovasc Disord
    Repisalud
    Instituto de Salud Carlos III (ISCIII)
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    Docusalut
    Conselleria de Salut i Consum del Govern de les Illes Balears
    Scientia
    Scientia. Dipòsit d'Informació Digital del Departament de Salut
    instname
    BMC Cardiovascular Disorders
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-10 (2023)

    Schlagwörter: adverse outcome, Myocardial Ischemia, clinical outcome, Pilot Projects, Coronary Artery Disease, anticoagulant agent, hydroxymethylglutaryl coenzyme A reductase inhibitor, surgery, study design, Postoperative Complications, 0302 clinical medicine, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Image Interpretation, Computer-Assisted::Tomography, X-Ray Computed::Computed Tomography Angiography, cardiovascular disease, Risk Factors, dipeptidyl carboxypeptidase inhibitor, postoperative complication, DISEASES::Wounds and Injuries::Thoracic Injuries::Heart Injuries, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::interpretación de imágenes asistida por ordenador::tomografía computarizada por rayos X::angiografía por tomografía computarizada, Prospective Studies, Cor - Imatgeria, pathophysiology, Factores de Riesgo, troponin T, adult, coronary artery disease reporting and data system, pilot study, beta adrenergic receptor blocking agent, Estudios Prospectivos, ivabradine, Isquemia Miocárdica, Humanos, 3. Good health, myocardial injury after non-cardiac surgery, female, Proyectos Piloto, Myocardial injury, coronary artery disea, coronary artery disease, prospective study, heart muscle ischemia, hypertension, Cirurgia - Complicacions, advanced cardiac imaging, Cor - Vàlvules - Ferides i lesions, complication, electrocardiogram, Enfermedad de la Arteria Coronaria, Pathophysiology, Article, cardiac imaging, cardiovascular magnetic resonance, 03 medical and health sciences, male, surgical patient, ENFERMEDADES::heridas y lesiones::traumatismos torácicos::lesiones cardíacas, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Postoperative Complications, Diseases of the circulatory (Cardiovascular) system, follow up, Humans, controlled study, human, Angiografia, preoperative period, Lesiones Cardíacas, computed tomographic angiography, Research, disease association, dyslipidemia, heart muscle injury, Noncardiac surgery, COVID-19, acetylsalicylic acid, thromboembolism, major clinical study, mortality, atenolol, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::complicaciones posoperatorias, Complicaciones Posoperatorias, hospital discharge, Heart Injuries, RC666-701, protein blood level, incidence, observational study, coronary angiography, Cardiac imaging

    Dateibeschreibung: application/pdf

  9. 9

    Autoren: Dogan, Z. Ergun, D.D. Durmus, S. et al.

    Weitere Verfasser: Dogan, Z. Ergun, D.D. Durmus, S. et al.

  10. 10

    Weitere Verfasser: Murat, Çimci Sophie, Degrauwe Marco, Roffi et al.

    Quelle: Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 51

    Dateibeschreibung: application/pdf

  11. 11
  12. 12
  13. 13

    Quelle: Journal of the American College of Cardiology. 73:2819-2828

  14. 14
  15. 15

    Weitere Verfasser: Rhodes Andrew Evans Laura E. Alhazzani Waleed et al.

    Quelle: Critical Care Medicine. 45:486-552

    Schlagwörter: vancomycin, analgesic agent, antibiotic agent, anticoagulant agent, antithrombin, bicarbonate, carbapenem, cefepime, ceftriaxone, cephalosporin derivative, cilastatin plus imipenem, ciprofloxacin, colistin, dalteparin, doripenem, drotrecogin, ertapenem, heparin, hypertensive agent, insulin, levofloxacin, low molecular weight heparin, meropenem, neuromuscular blocking agent, penicillin derivative, piperacillin plus tazobactam, procalcitonin, teicoplanin, thrombomodulin, unindexed drug, antiinfective agent, abdominal infection, acute kidney failure, adult respiratory distress syndrome, analgesia, antibiotic therapy, anticoagulant therapy, artificial ventilation, assessment of humans, blood sampling, bronchospasm, cohort analysis, conflict of interest, consensus, electronic medical record, evidence based medicine, fluid resuscitation, funding, Grading of Recommendations Assessment Development and Evaluation system, health care organization, health care policy, health care quality, hemodynamics, high frequency ventilation, high risk patient, human, infection, infection control, infection prevention, insulin treatment, lactic acidemia, meta analysis, pharmacodynamics, pharmacokinetic parameters, point of care testing, positive end expiratory pressure, practice guideline, priority journal, pulmonary artery catheter, purification, randomized controlled trial (topic), renal replacement therapy, resuscitation, Review, risk factor, sedation, sepsis, septic shock, stress ulcer, survival rate, teleconference, thrombosis prevention, venous thromboembolism, fluid therapy, intensive care, intensive care unit, nutritional support, Shock, Septic, standards, Anti-Bacterial Agents, Critical Care, Fluid Therapy, Humans, Intensive Care Units, Nutritional Support, Respiration, Artificial, Resuscitation, Sepsis, Development and Evaluation criteria, evidence-based medicine, Grading of Recommendations Assessment, guidelines, sepsis bundles, sepsis syndrome, Surviving Sepsis Campaign, antiinfective agent, beta 2 adrenergic receptor stimulating agent, corticosteroid, creatinine, dobutamine, DOPA, dopamine, epinephrine, erythropoietin, fresh frozen plasma, glucose, histamine H2 receptor antagonist, hydrocortisone, hypertensive factor, immunoglobulin, noradrenalin, omega 3 fatty acid, prokinetic agent, proton pump inhibitor, vasopressin, calcitonin, glucose blood level, vasoconstrictor agent, acute kidney failure, anemia, arterial blood, artery catheter, Article, bacteremia, bleeding, capillary blood, clinical trial, critically ill patient, crystalloid, drug combination, drug contraindication, drug withdrawal, erythrocyte transfusion, evidence based practice, fluid balance, gastrointestinal hemorrhage, heart muscle ischemia, hemoglobin determination, hypoxemia, immune deficiency, low drug dose, mortality, mycosis, neutropenia, noninvasive ventilation, oliguria, parenteral nutrition, pharmacokinetics, pulmonary artery catheterization, pyelonephritis, renal protection, respiratory failure, screening, supine position, thrombocyte transfusion, treatment duration, treatment response, vascular access, vascular access device, virus infection, blood, consensus development, critical illness, nutritional assessment, patient care planning, Shock, Septic, Anti-Bacterial Agents, Blood Glucose, Calcitonin, Critical Illness, Erythrocyte Transfusion, Nutrition Assessment, Patient Care Planning, Renal Replacement Therapy, Vasoconstrictor Agents, Evidence-based medicine, Grading of Recommendations Assessment, Development, and Evaluation criteria, Guidelines, Infection, Sepsis bundles, Sepsis syndrome, Septic shock, Critical Care and Intensive Care Medicine, 0302 clinical medicine, consensu, Respiration, Calcitonin/blood, and Evaluation criteria, 3. Good health, Artificial, Development, 03 medical and health sciences, vasoconstrictor agent, Anti-Bacterial Agents/therapeutic use, Septic/diagnosis, Critical Illness/therapy, Shock, Anti-Bacterial Agents, assessment of human, cohort analysi, abdominal infection, Sepsis/diagnosis, Anti-Bacterial Agents/administration & dosage, Critical Care/standards, Vasoconstrictor Agents/therapeutic use

    Dateibeschreibung: application/pdf

    Zugangs-URL: https://link.springer.com/content/pdf/10.1007%2Fs00134-017-4683-6.pdf
    https://pubmed.ncbi.nlm.nih.gov/28101605
    https://pubmed.ncbi.nlm.nih.gov/28098591
    https://openaccess.sgul.ac.uk/id/eprint/109148/1/Singer_Surviving%20Sepsis%20Campaign%20Guidelines_CCM.pdf
    https://openaccess.sgul.ac.uk/id/eprint/109147/1/Singer_Surviving%20Sepsis%20Campaign%20Guidelines.pdf
    https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F665c6955-bbeb-461d-850a-65580d885d99
    https://pure.fujita-hu.ac.jp/ja/publications/surviving-sepsis-campaign-international-guidelines-for-management
    https://publicatt.unicatt.it/handle/10807/92705
    https://scholars.houstonmethodist.org/en/publications/surviving-sepsis-campaign(102da601-cf6d-4035-9cf1-22d24e35faef).html
    https://experts.umn.edu/en/publications/surviving-sepsis-campaign-international-guidelines-for-management
    https://insights.ovid.com/crossref?an=00003246-201703000-00015
    https://rd.springer.com/article/10.1007/s00134-017-4683-6
    https://pure.fujita-hu.ac.jp/en/publications/surviving-sepsis-campaign-international-guidelines-for-management-2
    https://scholars.houstonmethodist.org/en/publications/surviving-sepsis-campaign(d45224a7-b1a3-4049-88f5-19aa0ef7f56a).html
    https://www.mendeley.com/catalogue/cbe77a30-86a8-3837-9b64-17b2331c4304/
    https://discovery.ucl.ac.uk/id/eprint/10052168/
    https://pubmed.ncbi.nlm.nih.gov/28101605/
    https://pure.amsterdamumc.nl/en/publications/2179c00a-61a9-42fa-bc13-a3a8f4325c55
    https://doi.org/10.1007/s00134-017-4683-6
    https://hdl.handle.net/10807/134246
    https://doi.org/10.1007/s00134-017-4683-6
    https://hdl.handle.net/11577/3312261
    https://doi.org/10.1007/s00134-017-4683-6
    https://hdl.handle.net/11585/663502
    https://doi.org/10.1007/s00134-017-4683-6
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009740698&doi=10.1007/s00134-017-4683-6&partnerID=40&md5=f9cd09bcdb9111e122fed4b6f29e38a2
    https://discovery-pp.ucl.ac.uk/id/eprint/10052167/
    https://discovery-pp.ucl.ac.uk/id/eprint/10052168/

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20